The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key regions has introduced considerable volatility. Investors are now facing the consequences of lower-cost a